CZ2002817A3 - Derivát aminu - Google Patents
Derivát aminu Download PDFInfo
- Publication number
- CZ2002817A3 CZ2002817A3 CZ2002817A CZ2002817A CZ2002817A3 CZ 2002817 A3 CZ2002817 A3 CZ 2002817A3 CZ 2002817 A CZ2002817 A CZ 2002817A CZ 2002817 A CZ2002817 A CZ 2002817A CZ 2002817 A3 CZ2002817 A3 CZ 2002817A3
- Authority
- CZ
- Czechia
- Prior art keywords
- formula
- group
- benzo
- chloro
- replaced
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Otolaryngology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19944604A DE19944604A1 (de) | 1999-09-17 | 1999-09-17 | Aminderivate |
Publications (1)
Publication Number | Publication Date |
---|---|
CZ2002817A3 true CZ2002817A3 (cs) | 2002-06-12 |
Family
ID=7922374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CZ2002817A CZ2002817A3 (cs) | 1999-09-17 | 2000-08-24 | Derivát aminu |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1212329A2 (pt) |
JP (1) | JP2003509511A (pt) |
KR (1) | KR20020027652A (pt) |
AU (1) | AU7412700A (pt) |
BR (1) | BR0014052A (pt) |
CA (1) | CA2387520A1 (pt) |
CZ (1) | CZ2002817A3 (pt) |
DE (1) | DE19944604A1 (pt) |
NO (1) | NO20021310D0 (pt) |
PL (1) | PL353319A1 (pt) |
WO (1) | WO2001021620A2 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10148883A1 (de) * | 2001-10-04 | 2003-04-10 | Merck Patent Gmbh | Pyrimidinderivate |
WO2003035653A1 (fr) * | 2001-10-26 | 2003-05-01 | Nippon Soda Co.,Ltd. | Compose pyridothienopyrimidine et son sel |
AR059901A1 (es) * | 2006-03-20 | 2008-05-07 | Bayer Pharmaceuticals Corp | Compuestos de tetrahidropiridotienopirimidina utiles para tratar o prevenir trastornos proliferativos celulares. |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1470356A1 (de) * | 1964-01-15 | 1970-04-30 | Thomae Gmbh Dr K | Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung |
US5869486A (en) * | 1995-02-24 | 1999-02-09 | Ono Pharmaceutical Co., Ltd. | Fused pyrimidines and pyriazines as pharmaceutical compounds |
DE19644228A1 (de) * | 1996-10-24 | 1998-04-30 | Merck Patent Gmbh | Thienopyrimidine |
DE19819023A1 (de) * | 1998-04-29 | 1999-11-04 | Merck Patent Gmbh | Thienopyrimidine |
US5948911A (en) * | 1998-11-20 | 1999-09-07 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives |
EP1167367A4 (en) * | 1999-03-30 | 2002-04-24 | Nippon Soda Co | THIENOPYRIMIDINE COMPOUNDS AND SALTS THEREOF, AND PROCESS FOR THE PREPARATION THEREOF |
DE19928146A1 (de) * | 1999-06-19 | 2000-12-21 | Merck Patent Gmbh | Thienopyrimidine |
-
1999
- 1999-09-17 DE DE19944604A patent/DE19944604A1/de not_active Withdrawn
-
2000
- 2000-08-24 AU AU74127/00A patent/AU7412700A/en not_active Abandoned
- 2000-08-24 EP EP00962374A patent/EP1212329A2/de not_active Withdrawn
- 2000-08-24 BR BR0014052-0A patent/BR0014052A/pt not_active Application Discontinuation
- 2000-08-24 CA CA002387520A patent/CA2387520A1/en not_active Abandoned
- 2000-08-24 CZ CZ2002817A patent/CZ2002817A3/cs unknown
- 2000-08-24 PL PL00353319A patent/PL353319A1/xx unknown
- 2000-08-24 KR KR1020027003415A patent/KR20020027652A/ko not_active Application Discontinuation
- 2000-08-24 WO PCT/EP2000/008256 patent/WO2001021620A2/de active Search and Examination
- 2000-08-24 JP JP2001524996A patent/JP2003509511A/ja active Pending
-
2002
- 2002-03-15 NO NO20021310A patent/NO20021310D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20021310L (no) | 2002-03-15 |
NO20021310D0 (no) | 2002-03-15 |
BR0014052A (pt) | 2002-05-21 |
AU7412700A (en) | 2001-04-24 |
CA2387520A1 (en) | 2001-03-29 |
WO2001021620A2 (de) | 2001-03-29 |
EP1212329A2 (de) | 2002-06-12 |
DE19944604A1 (de) | 2001-03-22 |
WO2001021620A3 (de) | 2001-11-01 |
PL353319A1 (en) | 2003-11-17 |
JP2003509511A (ja) | 2003-03-11 |
KR20020027652A (ko) | 2002-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100488429B1 (ko) | 포스포디에스테라제 v 억제효과를 가지는 티에노피리미딘 | |
SK7352003A3 (en) | Use of thienopyrimidines | |
SK7772000A3 (en) | Thienopyrimidine derivative, process for the preparation thereof, use thereof and pharmaceutical composition containing same | |
CZ20003976A3 (cs) | Derivát kondenzovaného thienopyrimidinu s PDE V inhibičním působením, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje | |
SK16899A3 (en) | Arylalkanoyl pyridazine derivative, process for its preparation and pharmaceutical composition containing the same | |
CZ2002736A3 (cs) | Derivát thienopyrimidinu, způsob jeho přípravy, jeho pouľití a farmaceutický prostředek, který ho obsahuje | |
CZ20014422A3 (cs) | Derivát thienopyrimidinu jako brzdič fosfodiesterázy, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje | |
CZ20031668A3 (cs) | Použití derivátů pyrazolo [4,3-d]pyrimidinu | |
CZ20032339A3 (cs) | Farmaceutický prostředek obsahující parazolo [4,3-d]pyrimidiny a nitráty nebo thienopyrimidiny a nitráty | |
CZ2002817A3 (cs) | Derivát aminu | |
CZ20031752A3 (cs) | Použití derivátů pyrazolo [4,3-d]pyrimidinu | |
JP4927299B2 (ja) | チエノピリミジン | |
CZ2002818A3 (cs) | Pouľití thienopyrimidinů |